Frontiers in medicine

acta diabetologica

Ocular immunology and inflammation

[1] Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study.

[2] effect of treatment for diabetic macular edema with triamcinolone acetonide using different methods of injection combined with laser photocoagulation

[3] a novel machine learning algorithm to automatically predict visual outcomes in intravitreal ranibizumab-treated patients with diabetic macular edema

[4] study on the change of retinal thickness and choroidal thickness and correlative factors for macular edema after ranibizumab injection

[5] clinical research on high oxygen permeable contact lens used after photorefractive keratectomy surgery

[6] effect of combined education on promoting nutritional behaviors of female students

[7] demographic, medical and visual aspects of dia- betic retinopathy (dr) and diabetic macular edema (dme) in south african diabetic patients*

[8] role of internal limiting membrane peeling for cases of recalcitrant diabetic macular edema

[9] Risk of transient vision loss after intravitreal aflibercept using vial-prepared vs. the novel prefilled syringe formulation.

[10] Retinal angiographic alteration in diabetic macular edema after dexamethasone implantation: a case report

[11] Retinal angiographic alteration in diabetic macular edema after dexamethasone implantation: a case report

[12] Expression of vascular infarction-related molecules after anti-vascular endothelium growth factor treatment for diabetic macular edema.

[13] Aqueous Humour Cytokine Changes with Intravitreal Dexamethasone Implant Injection for Diabetic Macular Edema.

[14] Aqueous Humor Cytokines and Long-Term Response to Anti–Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema

[15] Predicting optical coherence tomography-derived diabetic macular edema grades from fundus photographs using deep learning

[16] Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study.

[17] Axial Length as a Factor Associated With Visual Outcome After Vitrectomy for Diabetic Macular Edema

[18] Clinical preferences and trends of anti-vascular endothelial growth factor treatments for diabetic macular edema in Japan

[19] effect of treatment for diabetic macular edema with triamcinolone acetonide using different methods of injection combined with laser photocoagulation

[20] effects of fundus laser combined with anti-vegf therapy on serum levels of nos, vegf and il-6 in patients with diabetic macular edema

[21] uso intravítreo de la triamcinolona en el edema macular diabético use of intravitreous triamcinolone in cases of diabetic macular edema

[22] laser-based strategies to treat diabetic macular edema: history and new promising therapies

[23] a novel machine learning algorithm to automatically predict visual outcomes in intravitreal ranibizumab-treated patients with diabetic macular edema

[24] the results of comparative analysis of angiogenic and laser therapy for diabetic macular edema in diabetes type 2

[25] navigated macular laser decreases retreatment rate for diabetic macular edema: a comparison with conventional macular laser

[26] comparison of macular thickness in diabetic macular edema using spectral-domain optical coherence tomography and time-domain optical coherence tomography

[27] demographic, medical and visual aspects of dia- betic retinopathy (dr) and diabetic macular edema (dme) in south african diabetic patients*

[28] role of internal limiting membrane peeling for cases of recalcitrant diabetic macular edema

[29] intravitreal autologous plasmin as a therapeutic modality for diffuse diabetic macular edema

[30] combination of anti-vegf and laser photocoagulation for diabetic macular edema: a review

[31] comparisons of efficacy of intravitreal aflibercept and ranibizumab in eyes with diabetic macular edema